33.1 C
New Delhi
April 17, 2024
News Bridge

Covid19 | India’s DCGI Exempts Post-Approval Bridging Trial For Foreign Made Vaccines

In a new boost to India’s vaccination drive against Covid-19, foreign jabs approved by specific countries and WHO for emergency use will not need bridging trials in India, the Drug Controller General of India (DCGI) said on Wednesday.

The move will fast-track the import of doses needed to bolster vaccinations as well as clear the way for the entry of vaccines such as Pfizer and Moderna, who had requested the government for waivers like indemnity and post-approval local trials.

The exemption will, however, be limited to COVID-19 vaccines approved in India for restricted use in an emergency situation which is already approved for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or listed in WHO Emergency Use Listing (EUL) and has been already in use to inoculate masses in various countries.

Related posts

Kashmir Talks Today: Who All Are Attending And What To Expect?


PM Modi: ‘Kumbh Mela Should Now Only Be Symbolic To Strengthen Covid-19 Fight’


Govt. Issues New Media Accreditation Guidelines


U.N. Palestinian Agency Will Trim 267 Jobs, Citing U.S. Funding Cut


Lt Gen Manoj Pande To Take Over As New Chief of Indian Army


J&K Grenade Attack: Girl Succumbs, Death Toll Climbs To Two


Leave a Comment